Plain-English translation of NCT05931549 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is investigating the connection between stress hormones (particularly cortisol) and anorexia nervosa. Researchers want to understand how these hormones may affect mood, anxiety, and specific areas of the brain involved in emotion and memory in people with severe eating disorders.
Anorexia nervosa is a serious condition with the highest death rate of any psychiatric illness, and treatments haven't improved much in many decades. This study aims to uncover the biological mechanisms—particularly involving stress hormones and brain structure—that may drive and maintain the disorder, which could eventually lead to better treatments.
You likely qualify if…
You likely don't qualify if…
If you join, you will receive standard medical treatment for your eating disorder as usual. The study will involve brain imaging scans (such as MRI) to measure specific brain structures and blood tests to measure stress hormone levels. You'll also complete assessments about your mood, anxiety, and eating disorder symptoms.
AI-generated summary from trial data · Jun 20, 2026 · Not medical advice
Denmark
Enrollment target
~80 participants
Started
September 2023
Primary completion
December 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 50 Years
Sex
Female only
Last updated on clinicaltrials.gov in February 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
René K Støving, PhD
Odense University Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.